WallStreetZenWallStreetZen

NYSE: SOLV
Solventum Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Solventum earnings were $1.6B for the trailing 12 months ending Dec 31, 2025, with 222.7% growth year over year. The latest SOLV earnings report on Dec 31, 2025 announced Q4 2025 earnings of $63.0M, down 95% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, SOLV reported annual earnings of $1.6B, with 224.8% growth. The next SOLV earnings date is May 7, 2026.

SOLV past earnings growth

How has SOLV's earnings growth performed historically?

Company
222.74%
Industry
36.81%
Market
86.43%
SOLV's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
SOLV's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
SOLV's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

SOLV earnings history

Current Revenue
$8.3B
Current Earnings
$1.6B
Current Profit Margin
18.7%

SOLV Return on Equity

Current Company
36.7%
Current Industry
-7.8%
Current Market
28.9%
SOLV's Return on Equity (36.7%)... subscribe to Premium to read more.
High Return on Equity Performance

SOLV Return on Assets

Current Company
10.8%
Current Industry
2.4%
SOLV is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when SOLV announces earnings.

SOLV Return on Capital Employed

Current Company
18.46%
Current Industry
4.8%
SOLV has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SOLV vs Health Information Service Stocks

TickerEBITDAEarningsY/Y EarningsEPS
SOLV$2.55B$1.56B+53.03%$8.94
BTSG$545.40M$190.67M+39.18%$0.94
TEM-$112.57M-$245.03MN/A-$1.41
HQY$489.22M$215.20M+83.55%$2.50
WAY$389.85M$112.09MN/A$0.63
View Top Health Information Service Stocks

SOLV earnings dates

Next earnings date
May 7, 2026

Solventum Earnings Reports & History FAQ

What were Solventum's earnings last quarter?

On SOLV's earnings call on Invalid Date, Solventum (NYSE: SOLV) reported Q4 2025 earnings per share (EPS) of $0.36, up 100% year over year. Total SOLV earnings for the quarter were $63.00 million. In the same quarter last year, Solventum's earnings per share (EPS) was $0.18.

If you're new to stock investing, here's how to buy Solventum stock.

When does Solventum report earnings?

The next SOLV earnings date is Invalid Date. Add SOLV to your watchlist to be reminded of Solventum's next earnings date.

Is Solventum profitable or losing money?

As of the last Solventum earnings report, Solventum is currently profitable. Solventum's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $1.56 billion, a 224.84% increase year over year.

What was SOLV's earnings growth in the past year?

As of Solventum's earnings date in Invalid Date, Solventum's earnings has grown 222.74% year over year. This is 185.93 percentage points higher than the US Health Information Services industry earnings growth rate of 36.81%. SOLV earnings in the past year totalled $1.56 billion.

What are Solventum's earnings expectations?

The current EPS estimate for Solventum's earnings report in Invalid Date is $1.34.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.